PROUD PrEP study results published
Provision of PrEP in the UK will be cost-effective for gay men at high risk of HIV, model finds
High lifetime costs of treating HIV show importance of investing in prevention
Treatment outcomes no better with single tablet regimens than individual tablets
Pre-exposure prophylaxis (PrEP) stops 86% of HIV infections in PROUD study
